Institution Profile
Centre hospitalier universitaire Sainte-Justine
Contact Information
Research Center Contact
Institution
Facilities
CHU SAINTE-JUSTINE
-
3175 Chemin de la Côte-Sainte-Catherine, H3T 1C5, Montréal
-
CENTRE DE RÉADAPTATION MARIE ENFANT
-
5200 Rue Bélanger, Montréal, QC, H1T 1C9
-
Served Clientele / Population
Therapeutic Areas
Types of Research Projects
Recruitment initiatives
Our institution adheres to the values of Equity, Diversity, Inclusion, Accessibility (EDIA). A committee ensures that these principles are considered in the field of research during the development of protocols and the composition of teams, as well as in the recruitment of participants, which must be representative of the groups targeted by law and take into account the social determinants that impact representativeness.
Patient Partners in Clinical Research
Research Ethics Board
Frequency
Every 2 weeks
Calendar
Laboratories
Optilab Laboratory certified ISO 15189
FACT-certified cell therapy laboratory
Platforms and Technical Facilities
Research Pharmacy
Schedule
Receiving unblinded monitoring visits
Other departments involved in drug preparation
Oncology pharmacy, Cell therapy laboratory
Equipment
Level 3 Containment Laboratory
Schedule
Laboratory accreditations
Public Health Agency of Canada license
Equipment
Phase 1 Unit or Capacity
Overnight accommodation
Yes
Beds available for overnight stays
Pediatrics: 1
Oncology: as needed, use of inpatient beds.
Outpatient care reception
Yes
Number of chairs available for outpatient care
As needed, use of Day Center services.
Care services for the pediatric population
Yes
Number of chairs available for pediatric care
As needed, use of Day Center services.
Infusion Center or Chair
Description
Administration of chemotherapy, administration of blood product transfusions, etc.
Imaging
Equipment
Cardiopulmonary Function Testing Technical Platform
Reserved for research only
Schedule
Equipment
Flow Cytometry Platform
Reserved for research only
Schedule
Equipment
Pharmacology Platform
Reserved for research only
Schedule
Equipment
Image Analysis and Visualization Platform
Reserved for research only
Schedule
Equipment
Technical Platform in Neurophysiology (EEG / EMG)
Reserved for research only
Schedule
Equipment
Operating Room
Reserved for research only
Ophthalmology Equipment
Reserved for research only
Schedule
Sleep Laboratory
Reserved for research only
Schedule
Equipment
Biobank Service
Nom
Institutional Mother-Child Biobank of CHU Sainte-Justine
Description
The institutional mother-child biobank was created to provide all CHU Sainte-Justine researchers with the following services: extraction of nucleic acids (DNA and RNA); preparation of PBMC; centrifugation of biospecimens; preparation of plasma/serum; aliquoting; storage of biospecimens (blood, saliva, urine, breast milk, tissues, others); shipment of samples to external sites.
Other Platforms
- Cardiology Technical Platform It is not reserved exclusively for clinical research. Services are offered during the day only. Available equipment includes: Electrocardiograph (ECG), Transthoracic Echocardiogram (TTE), Transesophageal Echocardiogram (TEE), Fetal Echocardiogram, Ambulatory Blood Pressure Monitoring (ABPM), Holter, Vascular Resistance.
- Clinical Research Support Center (CRSC) The CRSC is reserved exclusively for research. CRSC services are offered mainly during the day, on weekdays, and include, among others: - Hiring and onboarding of new clinical research staff; - Support in assessing study feasibility (budget, negotiations, etc.); - Management of clinical trials according to quality standards and applicable regulations.
- Quality Assurance Office (QAO) The QAO is reserved exclusively for research. QAO services are offered during the day, on weekdays, and include: - Clinical trial monitoring services - Internal audit program - Support in preparing for external audits and regulatory inspections.
- Clinical Investigation Center (CIC) Work began in March 2025 on the construction of the future CIC at CHU Sainte-Justine. This new facility will significantly enhance our institution’s ability to participate in the most innovative clinical trials across numerous areas of interest.